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Abstract: The two-colour flow cytometry method applied in a routine enumeration of peripheral blood T lymphocyte subsets
reveals that in some patients the entire population of CD4+ lymphocytes seems to express CD8 determinants as well. However,
expression of the CD8 antigens on the cell surface is much lower in comparison with typical CD8+ cells. Moreover, in one-colour
staining with an anti-CD8 antibody, cells with weak CD8 expression are not observed and only one typical population of CD8+
lymphocytes is seen. Investigating this phenomenon, we showed that after washing patient cells in RPMI before CD4/CD8
staining, the CD4+ T cell population did not show CD8 "co-expression". These results suggest that CD4+ lymphocytes, which
seem to co-express CD8 antigen, in fact do not have this antigen on their surface.  Moreover, after the addition of patient plasma
to healthy donor cells prior to CD4/CD8 staining, a weak CD8 expression on normal CD4+ cells was noticed. Therefore we
can assume that the agent(s) causing this phenomenon is/are present in the plasma of some patients. Altogether, these
observations suggest that this phenomenon is nonspecific and probably results from cross-linking of anti-CD8 mAbs with
anti-CD4 mAbs caused by factor(s) present in plasma of some patient. However, identification of that/these factor(s) requires
further research.
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Introduction
Enumeration of the total number of T cells and major T
cell subsets (CD4+ and CD8+ cells) in peripheral blood
is a basic test for the diagnosis of both primary and
secondary immunodeficiencies [6]. A CD4/CD8 ratio
and absolute number of CD4+ T cells are crucial infor-
mation in monitoring AIDS progression [14].
The reference method for T cell subset enumeration
is flow cytometry. This method allows for simultaneous
detection of several different antigens on the cell surface
[4]. However, there are some biological factors contri-
buting to unspecific antibody binding which have a
significant effect on the cytometry readout of cell pheno-
type, e.g. Fc receptors, drugs (sulfamethazine showed
interaction with IgG [10]), some bacterial proteins (sta-
phylococcal protein A, streptococcal protein G and L [7,
8, 13]) and parasitic proteins (Toxoplasma gondii an
immunoglobulin binding protein [16]). These factors
may cause false positive (when e.g. mAbs bind Fc
receptors) or false negative (e.g. immunoglobulin bind-
ing proteins) cell staining, which affects the readout. It
may cause problems when the analysed cell subset oc-
curs only in a low frequency or is absent in healthy
individuals but present only in pathological states. This
is also true for a population of double-positive
CD4+/CD8+ T lymphocytes.
Developing T cells are CD4/CD8 positive and during
maturation in the thymus they lose either CD4 or CD8
and become single-positive mature T cells. Thus, co-ex-
pression of both CD4 and CD8 is rarely seen on circu-
lating T cells. Nevertheless, some mature T cells may
co-express these two molecules [11, 18]. Recently, it has
been reported that within the CD4+CD8+ double-posi-
tive T cell population several subpopulations of T cells
can be distinguished according to the intensity of CD4
and CD8 co-expression [17]. Based on the level of CD4
and CD8 expression, the authors described four different
CD4+/CD8+ double-positive T cell populations:
CD4dimCD8bright, CD4medCD8bright, CD4brightCD8bright, and
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CD4brightCD8dim. In some clinical conditions, e.g. thymo-
ma, allergy or graft reception, the number of peripheral
blood CD4+/CD8+ double-positive cells increases. In the
case of thymoma or allergy, these lymphocytes are no-
ticeable as additional T cell population with the express-
ion intensity of both markers comparable to the level of
CD4 and CD8 on single-positive populations, and can
be described as CD4brightCD8bright [3]. In graft recipients,
part of all CD4+ T cell population acquires dim CD8
expression. These cells are defined as CD4brightCD8dim
[5].
In this study we described a phenomenon of false
expression of CD8dim antigen on CD4bright T cells in some
patients during routine diagnostic tests of peripheral
blood lymphocyte subsets. In these patients, the entire
population of CD4+ lymphocytes seems to express CD8
determinant as well. We suggest that it is caused by
cross-linking of anti-CD8 (clone SK-1) mAbs with anti-
CD4 mAbs in the presence of the factor(s) from patient
plasma.
Materials and methods 
Patients. The samples of peripheral blood were collected during
routine diagnostic procedures from patients referred for immunologi-
cal examination. Among approximately 200 patients analysed year-
ly, about 10% exhibited abnormal fluorescence pattern after
anti-CD4 and anti-CD8 staining. These patients, both children and
adults, presented different clinical characteristics; hence this effect
cannot be connected to any nosological entity. No sex or age-related
differences were observed.
Cells staining and flow cytometry. Peripheral blood was drawn into
plastic tubes containing EDTA (Vacutainer System, BD Bioscien-
ces). 100 µl samples of whole blood were transferred to Falcon 2054
5 ml polystyrene tubes (BD Biosciences) and incubated for 30 min
at 4°C with pre-titered anti-CD4 and anti-CD8 monoclonal anti-
bodies (mAbs), labelled with FITC, PE or PE-Cy5, of the following
clones:
- anti-CD4: SK3, SK4 (IgG1), RPA-T4 (IgG1) (Becton Dickinson)
or MT310 (IgG1) (DakoCytomation);
- anti-CD8: SK1 (IgG1), RPA-T8 (IgG1) (Becton Dickinson),
DK25 (IgG1) (DakoCytomation). 
In some cases, cells were additionally stained with an anti-CD3
antibody conjugated with PerCP (IgG1) (Becton Dickinson). Sam-
ples stained with appropriate isotype controls were incubated in
parallel. After incubation, erythrocytes were lysed with FACS Lys-
ing Solution (Becton Dickinson) and leukocytes were washed
twice in PBS. The washed cells were suspended in 0.3 ml PBS
and analysed in FASCCalibur flow cytometer (BD Biosciences
Immunocytometry Systems, San Jose, CA) using CellQuest (ver-
sion 3.3) software. List mode data for 10 000 events in the
lymphocyte gate were acquired.
Analysis of patient plasma influence on lymphocyte staining.
50 µl of donor blood cells obtained after cell sedimentation were
mixed with 50 µl of patient plasma. Then, cells were stained with
mAbs, washed and analysed as described above. In cases where
double positive CD4+/CD8+ T lymphocytes were detected, cells were
incubated in RPMI 1640 medium at 37°C for 30 min. After incuba-
tion samples were washed, stained and analysed by flow cytometry.
Samples of blood from patients in whom we observed double-posi-
tive CD4+/CD8+ T cells were also incubated with murine IgG immu-
noglobulins (Sigma) or 1% newborn calf serum (Biochron, Berlin,
Germany) prior to routine sample staining.
Results and discussion
Figure 1 shows dot-plots obtained in flow cytometry
analysis of peripheral blood lymphocytes stained
with anti-CD4 FITC and anti-CD8 PE mAbs. Figure
1a shows a normal pattern of healthy donor lympho-
cyte staining with the majority of CD4+ cells, and a
smaller population of CD8+ cells, whereas figure 1b
shows a shift of CD4+ cells toward FL2 observed in
some patients, which gives the impression that the
entire CD4+ subpopulation acquired CD8 antigen.
This pattern of fluorescence is unusual, and differs
from that observed in patients with disturbed matur-
ation of lymphocytes in the thymus. In that case (Fig.
1c), lymphocytes stained in the same manner show
typical CD4+ and CD8+ T cells and an additional T
cell population expressing both markers at the same
level as the single positive CD4+ or CD8+ subpopula-
tions. These cells can be described as CD4brihgtCD8bright
T cells.
The population of CD4+/CD8+ cells observed in
some of our patients also differs from the population of
CD4brightCD8dim T cells observed by Creemers et al. [5]
in cardiac transplant recipients. In the latter patients only
a part of CD4+ cells (5-11%) demonstrate dim express-
ion of CD8 antigen, whereas in our cases the entire CD4
population seems to co-express CD8.
Fig. 1. FACS analysis of peripheral
blood leukocytes after two-colour stain-
ing using anti-CD4 FITC (clone SK-3)
and anti-CD8 PE (clone SK-1) mAbs.
Dot-plots show fluorescence pattern of
stained peripheral blood lymphocytes
from: (a) healthy donor, (b) patient with
false double-positive CD4+/CD8+ T
lymphocyte population and (c) patient
with disturbed maturation of lympho-
cytes in thymus.
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The question is whether the double-positive
CD4+/CD8+ population observed in blood of some pa-
tients is really the result of a weak co-expression of CD8.
To exclude the possibility of nonspecific binding of
mAbs to dead cells, lymphocytes were stained with
propidium iodide (PI). The viability of lymphocytes
checked by flow cytometry exceeded 95% (data not
shown). Next, we checked the co-expression of CD8
antigen on CD4+ T cells. Figure 2 shows that the use of
anti-CD8 PE-conjugated mAbs and single-colour flow
cytometry revealed only one typical population of CD8+
lymphocytes and no cells with dim expression of CD8
antigen. These data suggest that double-positive
CD4+/CD8+ cells observed in two-colour staining are an
artifact and their presence is apparently caused by inter-
actions of anti-CD8 mAbs with anti-CD4 mAbs.
Interestingly, using simultaneous staining with the
same clones of anti-CD4 and anti-CD8 mAbs but vice
versa conjugated with fluorochromes (CD4-PE, CD8-
FITC), "double positive" cells were also observed, but
in these conditions, CD8+ cells seemed to "acquire" CD4
expression. Figure 3 shows dot-plots obtained by flow
cytometry analysis of lymphocytes stained with anti-
CD4 PE and anti-CD8 FITC mAbs from healthy donor
(Fig. 3a) in comparison to patient cells, where CD8+
cells are noticeable as a shift toward FL2 fluorescence
(Fig. 3b). This finding suggests that the observed mAbs
interactions result from their cross-linking. However,
the cross-linking of mAbs was noticeable only as the
shift of cells stained with FITC-conjugated mAbs to-
ward FL2 channel, whereas a shift of PE stained cells
towards FL1 was not seen (regardless of whether anti-
CD4 or anti-CD8 mAbs were used). This can be ex-
plained by the fact that PE is a dye with high
fluorescence intensity, and even a small number of PE-
conjugated molecules of mAbs attached to lymphocytes
may cause visible changes in the intensity of FITC-la-
belled cell fluorescence. On the other hand, mAbs la-
belled with FITC, which is a considerably dimmer
fluorochrome, when attached to PE-labelled lympho-
cytes in a small number do not cause visible shift in
fluorescence.
Another set of experiments was designed to deter-
mine whether the clones of mAbs used for cell staining
are important for their cross-linking. We checked 4
different clones of anti-CD4 and anti-CD8 mAbs ob-
tained from different vendors (Fig. 4) and found that the
described phenomenon occurs only when SK1 clone of
anti-CD8 mAbs was used (Fig. 1).
Subsequently, we addressed the question of whether
the patient plasma is responsible for cross-linking of
anti-CD4 and anti-CD8 mAbs. To exclude cytotoxic
effect of patient plasma on donor cells, test with PI was
applied again to check cell viability. The viability of
lymphocytes checked by flow cytometry was 95% (data
not shown). By incubating lymphocytes obtained from
a healthy donor with patient plasma we were able to
transfer the factor(s) to the cell surface and to make
donor lymphocytes "double-positive" for CD4+/CD8+ in
flow cytometry (Fig. 5). Therefore, we concluded that
factor(s) causing cross-linking of anti-CD4 and anti-
CD8 mAbs is/are present in plasma of some patients.
However, after plasma removal cells remained "double-
positive". Standard cell washing before incubation with
mAbs did not abolish double-stained population, either.
Thus, we deduced that the factor(s) is/are bound to the cell
surface. The cell-attached membrane complex can be
removed from the cell surface by incubating cells in RPMI
1640 medium for at least 30 minutes at 37°C (Fig. 6).
Further studies revealed that nonspecific staining can
also be inhibited by incubating the patient blood with
murine IgG prior to staining, or by adding 1% newborn
calf serum. This would suggest a potential role for Fc
receptors, especially for their soluble form [9, 15]. How-
ever, as all used mAbs were of the same isotype and the
phenomenon is observed only in the presence of the SK1
clone of anti-CD8 mAbs, the role of soluble Fc receptors
can be ruled out. For the same reason some bacterial
products (proteins A, G, L) seem to play insignificant
Fig. 2. Population of CD8+ lymphocytes in patient with false double-
positive CD4+/CD8+ T cells in a single-colour FACS analysis using
anti-CD8 PE mAbs (clone SK-1). 
Fig. 3. FACS analysis of T lymphocyte subsets after two-colour
staining using anti-CD4 PE (clone SK-3) and anti-CD8 FITC (clone
SK-1) antibodies. Dot-plots show stained peripheral blood lympho-
cytes from (a) healthy donor and (b) patient with false double-posi-
tive CD4+/CD8+ T lymphocytes. 
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role in this phenomenon. The possible contributor in-
volved in nonspecific binding of mAbs might be micro-
particles shed from CD8+ lymphocytes and incorporated
into the plasma membrane of CD4+ T cells [1, 2, 12].
However, if this effect was mediated by microparticles
in a single-color staining with anti-CD8 mAbs, an addi-
tional population with weak CD8 signal would appear.
Moreover, microparticles can be ruled out as the CD8+
population labelled with FITC shifts toward FL2 fluo-
rescence what indicate that the observed phenomenon
depends on cross-linking of mAbs. However, this phe-
nomenon is undoubtedly connected with a disease pro-
cess, as in some of our patients, a false expression of
CD8 antigens disappeared after recovery and an anti-
CD4/anti-CD8 staining returned to the normal pattern. 
In summary, cross-linking of anti-CD4 and anti-
CD8 mAbs is probably responsible for nonspecific
staining of lymphocytes with both antibodies. This
phenomenon is apparently caused by factor(s) present
in plasma of some patients, and occurs only when the
SK1 clone of anti-CD8 is used. To avoid nonspecific
binding of this clone, cells should be incubated in
RPMI 1640 medium for at least 30 minutes at 37°C.
However, the identification of plasma factor(s) and the
Fig. 4. Flow cytometry analysis of patient T lymphocyte subsets
using various clones of anti-CD4 and anti-CD8 mAbs: (a) CD4 -
clone MT310, CD8 - clone DK25; (b) CD4 - clone SK3, SK4, CD8
- clone RPA-T8; (c) CD4 - clone RPA-T4, CD8 - clone RPA-T8; (d)
CD4 - clone RPA-T4, CD8 - clone RPA-T8. Staining of lymphocytes
with anti-CD8 mAbs of clone other than SK1 does not show double-
positive T cells.
Fig. 5. FACS analysis of T cell subsets in peripheral blood samples
of the same donor after (a) routine sample preparation and (b)
additional sample incubation with plasma of patient with false
double-positive CD4+/CD8+ T lymphocytes. The additional incuba-
tion of healthy donor lymphocytes with patient plasma makes donor
lymphocytes "double-positive" for CD4/CD8.
Fig. 6. FACS analysis of T cells subsets in peripheral blood of a
patient with false double-positive CD4+/CD8+ T lymphocytes after
(a) routine sample preparation and (b) cell incubation in RPMI 1640
medium (30 min, 37°C) and washing prior to staining. After incuba-
tion of cells in RPMI 1640 medium for at least 30 minutes at 37°C,
patient lymphocytes show typical pattern of staining.
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role of the SK1 clone in this phenomenon require further
studies. 
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